Palatin Technologies Inc. (PTN)

[seasonedwell]

We don't have the VRX/Addyi problem..... Approval will rock PTN....

But Tracy Valorie, who recently took charge of marketing the drug, said the prescription figures were deceiving. She said doctors tried to write 7,000 prescriptions since the drug went on sale in October, but only about 1,000 of them went through. That is because both doctors and pharmacists must be certified to prescribe and dispense the drug, given its side effects, which include low blood pressure, fainting, nausea, dizziness and sleepiness.

Ms. Valorie said Valeant anticipated Addyi sales of $100 million to $150 million in 2016. That is still well below the sales of male sexual performance pills like Viagra, though those work in completely different ways. Ms. Valorie said that about half of people with insurance have policies that will pay for Addyi under at least some circumstances.